Correction to: Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation
Crossref DOI link: https://doi.org/10.1208/s12249-020-01703-2
Published Online: 2020-05-19
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tashan, Emine
Karakucuk, Alptug
Celebi, Nevin
Text and Data Mining valid from 2020-05-19
Version of Record valid from 2020-05-19
Article History
First Online: 19 May 2020
Free to read: This content has been made available to all.